The Board of Directors of Suzhou Highfine Biotech Co., Ltd. has authorized a buyback plan on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
40.65 CNY | +1.70% | -7.40% | -32.26% |
May. 13 | Suzhou Highfine Biotech Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
Apr. 25 | Suzhou Highfine Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.26% | 605M | |
-8.74% | 60.39B | |
+65.24% | 45.4B | |
+14.54% | 38.12B | |
+0.50% | 31.28B | |
+7.38% | 19.67B | |
+10.83% | 16.52B | |
+7.90% | 13.8B | |
-5.22% | 12.96B | |
-23.61% | 12.42B |
- Stock Market
- Equities
- 301393 Stock
- News Suzhou Highfine Biotech Co., Ltd.
- Suzhou Highfine Biotech Co., Ltd. authorizes a Buyback Plan.